Publication: Role of endothelins in trinitrobenzene sulfonic acid-induced colitis in rats
No Thumbnail Available
Date
1999
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
KARGER
Abstract
To determine the role of endothelins (ET) on experimental colitis, following intracolonic trinitrobenzene sulfonic acid administration, rats were given orally either bosentan (BS), a nonselective ET receptor antagonist (100 mg/kg in 5% arabic gum), or arabic gum by gavage for 2 or 14 days. Macroscopic damage scores obtained in the vehicle (1.4 +/- 0.4), acute (4.8 +/- 0.6) and chronic (3.8 +/- 0.3) colitis groups were significantly higher than in the control group (0). BS treatment reduced the scores in both acute (3 +/- 0.5) and chronic (2.3 +/- 0.5) colitis groups. Myeloperoxidase (MPO) activities of colonic tissues were elevated in acute and chronic colitis groups (325.1 +/- 44.9 and 431.8 +/- 54.6 U/g wet weight) as compared with the control group (73.6 +/- 11 U/g wet weight). Plasma protein oxidation levels were found to be significantly increased in the chronic colitis group (1,158.1 +/- 63.4 nmol/ml) compared with the control, ethanol and acute colitis groups (274.3 +/- 23.1, 490 +/- 52.2 and 422.2 +/- 50.5 nmol/ml). BS treatment significantly reduced both the protein oxidation level (375.5 +/- 46.9 nmol/ml) and MPO activity (167.5 +/- 35.8 U/g wet weight). The results of the present study suggest the involvement of ETs in the pathogenesis of colonic injury in this animal model of colitis.
Description
Keywords
experimental colitis, bosentan, endothelins, colonic motility, myeloperoxidase activity, carbonyl content, INFLAMMATORY BOWEL-DISEASE, COLONIC INFLAMMATION, RECEPTOR ANTAGONIST, ULCERATIVE-COLITIS, MODEL, PEPTIDE, CELLS, CLONING, INJURY, IMMUNOREACTIVITY